Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Regeneron Pharmaceuticals (NQ:REGN)

654.48 +69.17 (+11.82%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 28, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,126,841
Open 612.02
Bid (Size) 653.00 (3)
Ask (Size) 654.48 (1)
Prev. Close 585.31
Today's Range 605.03 - 655.70
52wk Range 476.49 - 943.27
Shares Outstanding 91,779,465
Dividend Yield 0.27%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Regeneron (REGN) Q3 2025 Earnings Call Transcript
Regeneron (REGN) Q3 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
Uncover the latest developments among S&P500 stocks in today's session.
Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Tuesday as we examine the latest happenings in today's session. 
Via Chartmill

Performance

YTD
-8.5%
-8.5%
1 Month
+16.7%
+16.7%
3 Month
+17.3%
+17.3%
6 Month
+15.0%
+15.0%
1 Year
-29.5%
-29.5%

More News

Read More
Explore the top gainers and losers within the S&P500 index in today's session.
Via Chartmill
Why Are Regeneron (REGN) Shares Soaring Today
Via StockStory
Topics Artificial Intelligence
Earnings Scheduled For October 28, 2025
Via Benzinga
Nasdaq 100 Hits 26,000, Gold Falls Below $4,000: What's Moving Markets Tuesday?
Via Benzinga
Topics Economy
These S&P500 stocks are gapping in today's session
Via Chartmill
Wayfair, Qorvo, Celestica, United Parcel Service, Regeneron Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
These S&P500 stocks that are showing activity before the opening bell on Tuesday.
Via Chartmill
Regeneron's Q3 Earnings Outperform Expectations With Dupixent Strength Balancing Eylea Weakness
Via Benzinga
Regeneron's Earnings Took A Big Tax Hit, And Still Pounded Forecasts
Via Investor's Business Daily
Regeneron Pharmaceuticals (NASDAQ:REGN) Q3 2025 Earnings Beat Estimates
Via Chartmill
Topics Earnings
Regeneron (NASDAQ:REGN) Surprises With Strong Q3
Via StockStory
Regeneron Reports Third Quarter 2025 Financial and Operating Results
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire
Market's Perilous Peak: Is the U.S. Stock Market More Overvalued Than Ever?
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
A Preview Of Regeneron Pharmaceuticals's Earnings
Via Benzinga
Regeneron Earnings: What To Look For From REGN
Via StockStory
Topics Artificial Intelligence
Sanofi Soars as Dupixent Sales Near €5 Billion Amidst Intensifying Trump Drug Pricing Negotiations
Via MarketMinute
Topics Government World Trade
Immuno-Oncology Stocks Q2 Recap: Benchmarking Exact Sciences (NASDAQ:EXAS)
Via StockStory
Topics Artificial Intelligence
Reflecting On Immuno-Oncology Stocks’ Q2 Earnings: Natera (NASDAQ:NTRA)
Via StockStory
Topics Artificial Intelligence
Here's How Much $1000 Invested In Regeneron Pharmaceuticals 20 Years Ago Would Be Worth Today
Via Benzinga
The FDA Just Granted Its Speediest Review Ever. Disc Medicine, Others Fly.
Via Investor's Business Daily
FDA Unveils First Experimental Drugs Under Fast-Track Voucher Plan To Cut Drug Review Times
Via Benzinga
Libtayo® (cemiplimab) Recommended for EU Approval by the CHMP for Adjuvant Treatment of Cutaneous Squamous Cell Carcinoma (CSCC) with a High Risk of Recurrence After Surgery and Radiation
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire
Revolution Medicines, Disc Medicine, Regeneron Stocks Jump After-Hours As FDA Fast-Tracks 9 Drugs Under New Review Program
Via Stocktwits

Frequently Asked Questions

Is Regeneron Pharmaceuticals publicly traded?
Yes, Regeneron Pharmaceuticals is publicly traded.
What exchange does Regeneron Pharmaceuticals trade on?
Regeneron Pharmaceuticals trades on the Nasdaq Stock Market
What is the ticker symbol for Regeneron Pharmaceuticals?
The ticker symbol for Regeneron Pharmaceuticals is REGN on the Nasdaq Stock Market
What is the current price of Regeneron Pharmaceuticals?
The current price of Regeneron Pharmaceuticals is 654.48
When was Regeneron Pharmaceuticals last traded?
The last trade of Regeneron Pharmaceuticals was at 10/28/25 04:00 PM ET
What is the market capitalization of Regeneron Pharmaceuticals?
The market capitalization of Regeneron Pharmaceuticals is 60.07B
How many shares of Regeneron Pharmaceuticals are outstanding?
Regeneron Pharmaceuticals has 60B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.